共 50 条
- [22] Saliva soluble HLA as a potential marker of response to interferon-β1a in multiple sclerosis: A preliminary study Journal of Neuroinflammation, 4
- [25] Subcutaneous Recombinant Interferon-β-1a (Rebif®)A Review of its Use in the Treatment of Relapsing Multiple Sclerosis Drugs, 2011, 71 : 1865 - 1891
- [26] Treatment of early-onset multiple sclerosis with intramuscular interferonβ-1a: long-term results Neurological Sciences, 2007, 28 : 127 - 132
- [28] Prediction of treatment response to Interferon-β-1a based on MRI analysis at month 6 MULTIPLE SCLEROSIS, 2004, 10 (7032): : S228 - S228